George V. Migausky

Insider Reports History

Entity
Individual
Location
C/O Dyax Corp., 300 Technology Square, Cambridge, MA
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George V. Migausky:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Director Common Stock 121K $4.38M $36.15 Apr 2, 2024 Direct
REGENXBIO Inc. Director Common Stock 11.3K $178K $15.81 May 31, 2024 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 24.5K May 31, 2024 Direct
Immunovant, Inc. Director Stock Option (right to buy) 4.69K Apr 2, 2024 Direct

Insider Reports Filed by George V. Migausky

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. May 31, 2024 2 $0 4 Jun 4, 2024 Director
IMVT Immunovant, Inc. Apr 2, 2024 2 $0 4 Apr 4, 2024 Director
IMVT Immunovant, Inc. Dec 1, 2023 3 -$505K 4 Dec 5, 2023 Director
RGNX REGENXBIO Inc. Jun 2, 2023 2 $0 4 Jun 6, 2023 Director
IMVT Immunovant, Inc. Apr 12, 2023 2 $0 4 Apr 14, 2023 Director
IMVT Immunovant, Inc. Aug 17, 2022 2 $0 4 Aug 19, 2022 Director
RGNX REGENXBIO Inc. Jun 3, 2022 2 $0 4 Jun 7, 2022 Director
IMVT Immunovant, Inc. Jan 10, 2022 2 $0 4 Jan 12, 2022 Director
RGNX REGENXBIO Inc. Sep 3, 2021 1 $0 4 Sep 8, 2021 Director
RGNX REGENXBIO Inc. Sep 3, 2021 0 $0 3 Sep 8, 2021 Director
IMVT Immunovant, Inc. Aug 20, 2021 1 $53.6K 4 Aug 20, 2021 Director